A new risk factor for coronary artery disease can be detected by an ApoA1 mAb-based assay
This study aimed to find coronary artery disease (CAD) related apolipoprotein A1 (ApoA1) monoclonal antibody (mAb) and to evaluate the diagnostic value of the assay based on it. Patients with CAD diagnosed by coronary angiography (disease group, n = 180) and healthy subjects (control group, n = 199)...
Gespeichert in:
Veröffentlicht in: | Clinica chimica acta 2024-01, Vol.552, p.117700-117700, Article 117700 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This study aimed to find coronary artery disease (CAD) related apolipoprotein A1 (ApoA1) monoclonal antibody (mAb) and to evaluate the diagnostic value of the assay based on it.
Patients with CAD diagnosed by coronary angiography (disease group, n = 180) and healthy subjects (control group, n = 199) were recruited. The correlation between methods and CAD were evaluated by Spearman's rank correlation coefficients. Receiver operating characteristic (ROC) curve analysis was used to evaluate the auxiliary diagnostic value of methods for CAD. Odds ratios (ORs) of the test results in CAD were estimated using logistic regression analysis.
Measurements from an ApoA1 mAb were found significantly positively correlated with CAD (r = 0.243, P |
---|---|
ISSN: | 0009-8981 1873-3492 |
DOI: | 10.1016/j.cca.2023.117700 |